A closer look at the technologies used by Teligene Us
See more technologies
Teligene Us
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2060 E Avenida de los Arboles Ste D, Tho...Phone Number
+86 51286669213Website
www.teligenebio.cnRevenue
$14 MillionIndustry
About Teligene Us
Suzhou TeliGene Biotechnology Co., Ltd. specializes in the design, research, and industrialization of innovative small molecule targeted drugs for cancer treatment, particularly in areas with urgent clinical needs. Founded in 2011 by Dr. Zhang Dawei, a former chief scientist at Amgen, the company leverages advanced drug development technologies and has a strong focus on creating novel candidates with unique brain permeability. Their projects are currently in various clinical trial phases, aiming to provide new therapeutic options for patients with limited treatment alternatives. The company is committed to addressing unmet medical needs and plans to launch new drug products in the coming years, contributing to global health advancements.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Teligene Us
Compare insights from companies similar to Teligene Us, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Teligene Us
$14M
51-200
Private
-
2011
N/A
Teligene Us Tech Stack
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Teligene Us
Sign Up For FreeTo access detailed company insights
Suzhou TeliGene Biotechnology Co., Ltd. specializes in the design, research, and industrialization of innovative small molecule targeted drugs for cancer treatment, particularly in areas with urgent clinical needs. Founded in 2011 by Dr. Zhang Dawei, a former chief scientist at Amgen, the company leverages advanced drug development technologies and... Read More
